Multiplexed Cytokine Assessment of T- and NK-Cell Responses to Tumor Cells: Parallel Assessment of Biomarkers Associated with Efficacy, Safety, and Persistence

Breyanzi (lisocabtagene maraleucel) - BMS

Kymriah (tisagenlecleucel-T) - Novartis

ABIO-0501 - Abiogen

Yescarta (axicabtagene ciloleucel) - Gilead

Hans Layman1; Belinda Jackson2; Natalya Belkina, PhD2; Sripriya Ranganathan, PhD2; Jacob N Wohlstadter2

Nov 6, 2024